Your Article Summary
See Latest ArticlesA practical approach to using ciclosporin
Dermatology in Practice, 07/01/09
Ciclosporin is an immunosuppressant drug used in dermatology to treat patients with severe or recalcitrant psoriasis, or with severe atopic eczema. It has important adverse effects, particularly on the kidneys, so careful counselling and monitoring are required.
Related Articles
Sequential phase II Southwest Oncology Group studies (S0112 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with ciclosporin, in older patients with previously untreated acute myeloid leukaemia
British Journal of Haematology, 10/16/09
Relevance Score: 84%
Limited Sampling Models and Bayesian Estimation for Mycophenolic Acid Area under the Curve Prediction in Stable Renal Transplant Patients Co-Medicated with Ciclosporin or Sirolimus
Clinical Pharmacokinetics, 10/15/09
Relevance Score: 80%
Today in Adverse Drug Reactions...keeping you current
Receive free subspecialty "5-minute updates" via email
Vigabatrin: a comprehensive review of drug properties including clinical updates following recent FDA approval
Expert Opinion in Pharmacotherapy, 12/09/09
Triptans, Serotonin Agonists, and Serotonin Syndrome (Serotonin Toxicity): A Review
Headache: The Journal of Head and Face Pain, 12/08/09
Review: aspirin reduces vascular events but increases bleeding in primary and secondary prevention
Evidence-Based Medicine, 12/07/09